Search filters

List of works by Nancy U Lin

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)†

scientific article published on 23 September 2020

A Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer

scientific article published on 21 July 2020

A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases ⬇️

scientific article published on June 22, 2011

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer

scientific article published on 06 October 2020

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

scientific article published on 12 April 2013

A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases

scientific article

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab ⬇️

scientific article published on March 15, 2012

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer

scientific article published on 5 May 2013

A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases

scientific article published on 20 September 2019

A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast

scientific article published in 2021

AT-47PHASE I TRIAL OF INTRATHECAL TRASTUZUMAB IN HER2 POSITIVE LEPTOMENINGEAL METASTASES

Abstract CT026: A phase II trial of neratinib (NER) or NER plus fulvestrant (FUL) (N+F) in HER2 mutant, non-amplified (HER2mut) metastatic breast cancer (MBC): Part II of MutHER

scientific article published in 2021

Abstract OT2-16-02: Open-label, phase 3b/4 study of trastuzumab deruxtecan (T-DXd) in patients with or without baseline brain metastasis with advanced/metastatic human epidermal growth factor receptor 2–positive breast cancer: DESTINY-Breast12

scientific article published in 2023

Abstract P5-12-02: <i>PTEN</i> alterations and tumor mutational burden (TMB) as potential predictors of resistance or response to immune checkpoint inhibitors (ICI) in metastatic triple-negative breast cancer (mTNBC)

scientific article published on 11 May 2019

Abstract PS4-25: Comprehensive genomic analysis reveals molecular correlates of response to immune checkpoint inhibitors (ICI) in metastatic triple-negative breast cancer (mTNBC)

scientific article published on 15 February 2021

Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer

scientific article published on 28 July 2020

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies

scientific article published on 10 December 2018

Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial

scientific article published on 14 October 2019

Advances in adjuvant endocrine therapy for postmenopausal women

scientific article published on February 2008

Aggressive Subsets of Metastatic Triple Negative Breast Cancer

scientific article published on 31 July 2019

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.

scientific article published on 3 January 2018

Attitudes of patients with metastatic breast cancer toward research biopsies

scientific article

Author's reply: Use of discard pleural fluid in molecular research

scientific article published on January 2012

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

scientific article published on 24 April 2020

BM-07GENOMIC CHARACTERIZATION OF BRAIN METASTASES REVEALS BRANCHED EVOLUTION AND METASTASIS-SPECIFIC MUTATIONS

Barriers to Accrual and Enrollment in Brain Tumor Trials

scientific article published on 07 June 2019

Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers

scientific article published on 07 May 2020

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today

scientific article published on 19 February 2020

Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study

scientific article

Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.

scientific article

Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype

scientific article published on 12 September 2012

Brain metastases: the HER2 paradigm

scientific article published on March 2007

Brain metastasis: opportunity for drug development?

scientific article published on December 2012

Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management

scientific article published on January 2017

Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases

scientific article published on 13 April 2019

Breast cancer-specific survival by age: Worse outcomes for the oldest patients

scientific article published on 02 March 2018

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

scientific article published on 2 October 2017

CMET-04. CEREBROSPINAL FLUID CIRCULATING TUMOR CELLS (CSF CTC) FOR PATIENT MONITORING AND RESPONSE TO TREATMENT

CMET-20. EVIDENCE OF CNS RESPONSE OF PEMBROLIZUMAB FOR LEPTOMENINGEAL CARCINOMATOSIS AT A SINGLE CELL RESOLUTION

CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY

CNS metastases in breast cancer

scientific article published in September 2004

CNS metastases in breast cancer: old challenge, new frontiers

scientific article published on December 2013

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

scientific article published on 06 June 2020

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

scientific article

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.

scientific article published on September 2013

Chemotherapy Agents in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Time to Step Out of the Limelight ⬇️

scientific article published on December 13, 2010

Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial

scientific article published on 08 December 2020

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era.

scientific article published on 23 January 2013

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

scientific article published in January 2018

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network ⬇️

scientific article published on April 27, 2012

Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study

scientific article

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases

scientific article published on 06 June 2016

Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM)

scientific article published on 12 February 2020

Correction to: Systemic Therapy of Central Nervous System Metastases of Breast Cancer

scientific article published on 17 May 2019

Dose density in breast cancer: a simple message?

scientific article

Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction

scientific article published on 9 November 2009

Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea

scientific article published on 17 May 2010

Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide follow

scientific article published on 30 January 2008

Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?

scientific article published on 6 February 2018

Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study

scientific article published on 10 February 2014

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial

scientific article published on 03 September 2020

Effect of Very Small Tumor Size on Cancer-Specific Mortality in Node-Positive Breast Cancer ⬇️

scientific article published on May 23, 2011

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

scientific article

Estrogen, Progesterone and HER2 Receptor Discordance Between Primary Tumor and Brain Metastases in Breast Cancer and Its Effect on Treatment and Survival

scientific article published on 08 February 2020

Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology

scientific article published on 20 April 2010

Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center

scientific article published in December 2016

Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study

scientific article published on 27 February 2017

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

scientific article published on 14 March 2016

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

scientific article published on 26 September 2015

Genomic characterization of de novo metastatic breast cancer

scientific article published on 08 December 2020

Genomic features of rapid versus late relapse in triple negative breast cancer

scientific article published on 18 May 2021

Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap

scientific article published on 28 September 2009

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

scientific article published on 25 March 2020

HSP90 as a platform for the assembly of more effective cancer chemotherapy ⬇️

scientific article published on December 24, 2011

HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models

scientific article

Heterogeneity of breast cancer and implications of adjuvant chemotherapy

scientific article

High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer

scientific article published on 31 October 2011

Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?

scientific article published on 28 September 2012

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials

scientific article published on 15 November 2019

Imaging in the evaluation and follow-up of early and advanced breast cancer: When, why, and how often?

scientific article

Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria

scientific article published on 03 August 2018

Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study ⬇️

scientific article published on October 1, 2012

Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation

scientific article published on 31 August 2017

Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer

scientific article published on 01 July 2018

Importance of Extracranial Disease Status and Tumor Subtype for Patients Undergoing Radiosurgery for Breast Cancer Brain Metastases ⬇️

scientific article published on July 15, 2012

In regard to Yamamoto et al.

scientific article published in November 2012

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study

scientific article published on 24 April 2017

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab

scientific article published on 4 March 2013

Increasing Burden of Prior Authorizations in the Delivery of Oncology Care in the United States

scientific article published on 20 August 2018

Informational needs and the quality of life of patients in their first year after metastatic breast cancer diagnosis

scientific article published in October 2014

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment

scientific article published on 24 January 2019

Integrative multiomics-histopathology analysis for breast cancer classification

scientific article published on 29 November 2021

Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review

scientific article published on 18 August 2008

International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

scientific article published on 17 April 2013

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

scientific article published on 29 May 2020

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

Local control after fractionated stereotactic radiation therapy for brain metastases

scientific article published on 25 July 2014

Long Term Follow-Up of National Surgical Adjuvant Breast and Bowel Project Trial B-31: How Well Can We Predict Cardiac Toxicity With Trastuzumab? ⬇️

scientific article published on September 17, 2012

Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer

scientific article published on 26 August 2013

Management of brain metastases according to molecular subtypes

scientific article published on 01 September 2020

Measuring opportunities to improve timeliness of breast cancer care at Dana-Farber/Brigham and Women's Cancer Center.

scientific article

Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade

scientific article published on 05 December 2018

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.

scientific article published on 2 October 2017

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

scientific article published on 21 September 2021

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

scientific article published on January 2006

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study

scientific article

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

scientific article published in February 2009

Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies

scientific article

NEURO/MEDICAL ONCOLOGY

NI-23BRAIN BREAST METASTASES RESPOND TO ANTI-ANGIOGENIC THERAPY BY MODES OF VASCULAR NORMALIZATION

scientific article published in November 2014

NIMG-63. ADVANCED IMAGING FOR ASSESSING VOLUMETRIC RESPONSES IN BRAIN METASTASES TREATED WITH CHECKPOINT BLOCKADE

scientific article published on 5 November 2018

New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors

scientific article

Novel approaches to advanced breast cancer: bevacizumab and lapatinib

scientific article published on March 2007

O7.01RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA FOR BRAIN METASTASES.

scientific article published in September 2014

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center

scientific article published on 16 September 2020

Optimal use of aromatase inhibitors: to lead or to follow?

scientific article published on 11 June 2007

Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time

scientific article published on 10 March 2008

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

scientific article

P15.13THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE: A TOOL TO ASSESS NEUROLOGIC FUNCTION FOR INTEGRATION IN THE RADIOLOGIC ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA.

scientific article published in September 2014

PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers

scientific article published on 26 October 2015

PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling

scientific article published on 07 December 2015

Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer

scientific article published in March 2017

Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy

scientific article published on 23 April 2014

Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers

scientific article published on 03 October 2019

Perceptions and needs of women with metastatic breast cancer: a focus on clinical trials

scientific article published on 25 March 2013

Perceptions of patients with early stage breast cancer toward research biopsies

scientific article published on 15 December 2020

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

scientific article published on 02 November 2020

Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases

scientific article published on 24 May 2020

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomogr

scientific article

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions

scientific article published on 08 March 2007

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer.

scientific article

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

scientific article published on 05 July 2019

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

scientific article published on 30 November 2020

Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer

scientific article published in April 2008

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022

scientific article published on 22 August 2019

Prior Authorization for Medications in a Breast Oncology Practice: Navigation of a Complex Process.

scientific article published on 28 February 2017

Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases

scientific article published on 26 April 2019

Prospective clinical experience with research biopsies in breast cancer patients

scientific article published on 11 October 2013

Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 18 June 2020

Quality of Life in Long-Term Survivors of Metastatic Breast Cancer ⬇️

scientific article published on April 1, 2012

RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group

scientific article published on 26 May 2016

RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis

scientific article published on 12 March 2019

RECIST 1.1-Update and clarification: From the RECIST committee.

scientific article published on 14 May 2016

Racial differences in outcomes for patients with metastatic breast cancer by disease subtype

scientific article

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases ⬇️

scientific article published on June 26, 2011

Randomized trial of a physical activity intervention in women with metastatic breast cancer

scientific article

Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation

scientific article published on 18 June 2019

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update

scientific article published on 25 June 2018

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update Summary

scientific article published on 10 July 2018

Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.

scientific article

Reply to Garcia J. et al

scientific article published on 11 May 2017

Reply to H.L. McArthur et al.

scientific article published on 17 November 2014

Reply to M.C. Chamberlain et al

Reply to V. Pitini et al.

scientific article published in June 2013

Response assessment criteria for brain metastases: proposal from the RANO group.

scientific article

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib

scientific article published on 27 May 2020

Response to Letter to Editor

scientific article published on 21 August 2020

Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis

scientific article published on 29 November 2019

Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer ⬇️

scientific article published on April 29, 2011

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

scientific article published on 20 February 2020

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

scientific article published on 31 May 2022

Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors

scientific article published on 14 September 2011

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.

scientific article published on 6 November 2017

Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer

scientific article published on 13 March 2020

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk

scientific article published on 22 June 2020

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

scientific article

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

scientific article published on 01 June 2020

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

scientific article

Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium

scientific article published on 07 January 2019

Subtype switching in breast cancer brain metastases: a multicenter analysis

scientific article published on 23 January 2020

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

scientific article published on 27 December 2011

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

scientific article published on 15 September 2020

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update

scientific article published on 25 June 2018

Systemic Therapy of Central Nervous System Metastases of Breast Cancer

scientific article published on 08 April 2019

Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis

scientific article published on 17 January 2020

Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline

scientific article published on 05 May 2014

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

scientific article published on 18 February 2020

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

scientific article

TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.

scientific article published on 16 March 2015

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

scientific article published on 12 March 2019

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

scientific article published on 29 October 2020

The Influence of Radiology Image Consultation in the Surgical Management of Breast Cancer Patients.

scientific article

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

scientific article published in May 2017

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer

scientific article published in 2022

The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.

scientific article published on 6 March 2013

The ethical use of mandatory research biopsies ⬇️

scientific article published on August 2, 2011

The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor positive metastatic breast cancer

scientific article published on 13 May 2020

Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.

scientific article

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

scientific article published on February 2016

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.

scientific article

Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational study

scientific article published on 10 November 2017

Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab

scientific article published on 2 August 2016

Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers

scientific article

Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012.

scientific article published on 08 August 2012

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

scientific article published on 11 December 2019

Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer

scientific article published on 04 February 2020

Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer

scientific article published on 01 January 2006

Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center

scientific article published on 01 October 2014

Unraveling the clinicopathological features driving the emergence of mutations in metastatic breast cancer

Updates in the management of brain metastases.

scientific article

Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.

scientific article

Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy

scientific article published in January 2014

Using Quality Improvement to Increase Access to Palliative Care

scientific article published on 16 November 2020

Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center

scientific article

Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States

scientific article published on 13 January 2018

Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer

scientific article

Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study

scientific article

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional Portuguese cohort study.

scientific article published on 24 July 2016

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study

scientific article published on 10 March 2015

Voxelwise single-subject analysis of imaging metabolic response to therapy in neuro-oncology

scientific article

Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond

scientific article published on 25 May 2020

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

scientific article published on 2 March 2017

p16<sup>INK4A</sup>-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases

scientific article published on 18 March 2022

Paulina is supported by:

About Paulina

Help